Matrixx Must Transition Zicam Customers To Oral Products As Options Narrow

Salvaging the Zicam brand by shifting consumers to its oral delivery products will be crucial to the survival of Matrixx Initiatives, as the firm's strategic options narrow in the wake of a major recall